UNIVERSITY OF ILLINOIS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1859-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.illinois.edu
Lycopene in Preventing Prostate Cancer in Healthy Participants
Phase 1
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-10-08
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- University of Illinois at Chicago
- Registration Number
- NCT00093561
- Locations
- 🇺🇸
University of Illinois at Chicago Cancer Center, Chicago, Illinois, United States
Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
Phase 1
- Conditions
- Breast Cancer
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 36
- Registration Number
- NCT00002616
- Locations
- 🇺🇸
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Phase 1
- Conditions
- Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
- First Posted Date
- 2004-08-13
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 46
- Registration Number
- NCT00003251
- Locations
- 🇺🇸
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
Phase 2
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- University of Illinois at Chicago
- Registration Number
- NCT00003568
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸Comprehensive Cancer Center at Our Lady of Mercy Medical CenterOur, Bronx, New York, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Lycopene In Preventing of Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- University of Illinois at Chicago
- Registration Number
- NCT00006078
- Locations
- 🇺🇸
University of Illinois Medical Center, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath